Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Bright Minds Biosciences Inc. (DRUG) had Consolidated Net Income/Loss of $-2.06M for the most recently reported fiscal year, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-2.06M |
|
-- |
|
-- |
|
$2.07M |
|
$-2.07M |
|
$0.02M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
$-2.06M |
|
|
Consolidated Net Income/Loss |
$-2.06M |
$-2.06M |
|
$-2.07M |
|
$-2.02M |
|
4.31M |
|
4.31M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$4.40M |
|
-- |
|
$0.09M |
|
$4.49M |
|
$0.39M |
|
$0.03M |
|
$0.03M |
|
$0.42M |
|
$4.07M |
|
$4.07M |
|
$4.07M |
|
4.52M |
|
| Cash Flow Statement Financials | |
$-1.36M |
|
-- |
|
$0.60M |
|
$4.96M |
|
$4.20M |
|
$-0.76M |
|
$0.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.32 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.36M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-50.61% |
|
-50.61% |
|
-45.90% |
|
-50.25% |
|
$0.90 |
|
$-0.32 |
|
$-0.32 |
|